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Abstract
Background The complications discussed with patients by surgeons prior to surgery vary, because no consensus on
major complications exists. Such consensus may improve informed consent and shared decision-making. This study
aimed to achieve consensus among vascular surgeons on which complications are considered ‘major’ and which
‘minor,’ following surgery for abdominal aortic aneurysm (AAA), carotid artery disease (CAD) and peripheral artery
disease (PAD).
Methods Complications following vascular surgery were extracted from Cochrane reviews, national guidelines, and
reporting standards. Vascular surgeons from Europe and North America rated complications as major or minor on
five-point Likert scales via an electronic Delphi method. Consensus was reached if C 80% of participants scored 1 or
2 (minor) or 4 or 5 (major).
Results Participants reached consensus on 9–12 major and 6–10 minor complications per disease. Myocardial
infarction, stroke, renal failure and allergic reactions were considered to be major complications of all three diseases.
All other major complications were treatment specific or dependent on disease severity, e.g., spinal cord ischemia,
rupture following AAA repair, stroke for CAD or deep wound infection for PAD.
Conclusion Vascular surgeons reached international consensus on major and minor complications following AAA,
CAD and PAD treatment. This consensus may be helpful in harmonizing the information patients receive and
improving standardization of the informed consent procedure. Since major complications differed between diseases,
consensus on disease-specific complications to be discussed with patients is necessary.
The complications surgeons choose to discuss with their
patients prior to surgery differ [1, 2]. According to
informed consent guidelines, surgeons are obliged to dis-
cuss the major and most frequently occurring complica-
tions with their patient [3, 4]. However, no consensus exists
on which specific complications are considered to be
major.
Evidently, there are no objective criteria to determine
whether complications are major or minor. In these situa-
tions, the Delphi method can help fill the knowledge gap by
reaching consensus using the knowledge and personal
opinions of experts. The RAND corporation originally
developed the Delphi method to predict the impact of
technology on warfare in the 1950s [5]. Since then, its use
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has expanded into other areas, including healthcare. For
example, using the Delphi method, experts have reached
consensus on which complications to discuss with patients
prior to treatment for varicose veins, colorectal cancer and
skin cancer [6–8].
Consensus on which specific major complications to
discuss with patients will harmonize how surgeons inform
their patients and obtain informed consent. Moreover,
informing patients about potential major complications
allows them to assess their values and preferences
regarding available treatment options.
Patients with vascular surgical diseases may particularly
benefit from this assessment as there is usually a conservative,
endovascular and/or open surgical treatment option available,
each with their own benefits and complications [9].
Thus, the aim of this study was to reach consensus on
which complications are considered ‘major’ and which
‘minor’ following treatment for abdominal aortic aneurysm
(AAA), carotid artery disease (CAD) and peripheral artery
disease (PAD) using the knowledge and personal opinions
of vascular surgeons from Europe and North America.
Methods
Study design
The Delphi method typically presents participants with 3–5
rounds of a fixed set of questions [10]. After each round,
participants receive a summary of responses from the
previous round. Based on this summary, participants may
adjust their answers in the following round. This process
continues until participants reach consensus or if no addi-
tional consensus is expected. The Delphi method allows
researchers to include a large number of participants,
anonymously and throughout the world. It also prevents
one expert from dictating consensus [10].
Participants
Participants in a Delphi study are usually experts on the
topic on which consensus is sought. Their scientific and
practical knowledge of potential complications, and their
experience in the consulting room, equip vascular surgeons
with an expert opinion on whether a complication is major
or minor. This study focused on complications following
elective treatment for AAA, CAD and/or PAD. Thus,
vascular surgeons were eligible for participation if they
treated patients with one of these diseases and had either
published articles about the disease or performed C5
interventions for this disease during the previous year.
With permission from the organisers, vascular surgeons
who had attended the 2015 VEITH symposium were
contacted via personal email and asked to participate.
Dutch vascular surgeons were contacted via the Dutch
Society of Vascular Surgery. Participants were selected in
alphabetical order until the email addresses of at least 50
vascular surgeons per disease had been obtained.
Complications
One researcher extracted all reported complications from
reference articles used in Cochrane systematic reviews on
AAA and CAD [11, 12]. The Dutch peripheral vascular
disease guideline was used for PAD [13]. Complications
included 30-day and long-term complications as well as
complications from open and endovascular surgery. Death
was not included as a complication in this study as the
authors presumed all participants would consider death to
be a major complication. A second researcher verified the
extraction. From the literature, 24–30 complications per
disease were extracted. Following the first round, partici-
pating experts were asked to suggest complications they
deemed missing from the survey. These were added in the
second round.
Complications can have differing consequences that
affect whether a complication is viewed as major or minor.
Therefore, complications were extended by a description
based on the three-tiered severity scoring of the Society for
Vascular Surgery (SVS) reporting standards [14–16]. An
example of this is the consequences of spinal cord ischemia
which are mild if resolved within 24 h. However, conse-
quences can also be regarded as moderate if the ability to
walk without support is regained within one month, and as
severe if paraplegia remains permanent. If a complication
was not addressed by the SVS reporting standards, the
Clavien–Dindo classification combined with information
from reference articles or daily practice was used to present
the differing consequences [17]. In the surveys, compli-
cations were presented in alphabetical order to avoid
ranking bias.
Delphi method modifications
The researchers made several modifications to the classic
Delphi method [10]. First, an electronic Delphi method was
used, i.e., the surveys were developed online and sent via
email using the online tool SurveyMonkey (San Mateo,
California, USA). Second, each disease had its specific list
of complications and its own survey. Hence, we actually
carried out three separate studies. Third, to avoid lengthy
surveys containing 30 complications, each with three dif-
fering consequences, the first Delphi round started by
presenting the moderate severity levels of each complica-
tion. If participants deemed this complication as major, it
was assumed that they would also rate the corresponding
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severe level as major. In the next round, participants were
asked to rate the mild level of this complication. Similarly,
if they deemed the moderate complication to be minor, the
mild level was also considered as minor. In the next round,
participants were asked to rate the severe level of the same
complication. Figure 1 provides an overview of this
process.
Consensus
In every round, participants rated each complication on a
five-point Likert scale, ranging from 1 (definitely minor) to
5 (definitely major). No strict guidelines exist within the
Delphi method concerning the appropriate level of con-
sensus. This level depends on the severity of the issue on
which consensus is sought. A 51% level of consensus may
be acceptable for decisions about a new hospital logo,
whereas a 100% level of consensus is required for life or
death situations. The researchers decided that an 80% level
of consensus should suffice for this study [10]. Thus, if
C80% of participants gave a complication a Likert score of
1 or 2, it was deemed minor. Likewise, if C80% of par-
ticipants gave a complication a Likert score of 4 or 5, it was
deemed major.
Number of rounds
Delphi studies have a minimum of two rounds. The max-
imum number of rounds depends on the number necessary
to reach either consensus on all questions or the stage at
which no additional consensus is expected. This Delphi
study originally comprised four rounds. Post hoc, we added
a fifth round to limit the possibility of missing major
complications for which participants had not reached
consensus on the moderate level. Participants had two
weeks to complete each round.
Data analysis
The researchers assessed the reliability of the surveys by
calculating the internal consistency of the first Delphi
round expressed by the Cronbach’s alpha, using IBM SPSS
Statistics v.23 (Armonk, New York, USA). A Cronbach’s
alpha value of 0.7 or higher is regarded as an accept-
able level of internal consistency, while a value of 0.9 or
higher is considered excellent [18].
Following each round, the Likert scores from all par-
ticipants for each complication were collected. The online
survey tool automatically turned these scores into per-
centages. In the next round, the survey reported these
percentages back to participants anonymously. Figure 2
shows an example of this feedback.
Results
Sixty-three vascular surgeons were invited for the AAA
survey, 50 for CAD and 52 for PAD. Nine vascular sur-
geons participated in surveys for more than one of these
diseases.
In the first round, 19 of 63 surgeons accepted our invi-
tation for AAA, 21 of 50 for CAD and 17 of 52 for PAD.
The response rates were 30%, 42% and 33%, respectively.
Annually, these participants performed a median number of
48, 50 and 175 interventions for AAA, CAD and PAD,
respectively. In the final round, 11 experts in AAA, 16 in
CAD and 14 in PAD continued participation, resulting in a
25% total response rate.
Vascular surgeons from 13 different countries partici-
pated in this study. Thirty-two surgeons were affiliated to
European centers and 14 to North American centers (see
Fig. 3). Table 1 shows the characteristics of the partici-
pating surgeons. These characteristics did not show statis-
tically significant differences between those surgeons who
did or did not participate.
In round 1, Cronbach’s alpha scores were 0.96, 0.97 and
0.95 for AAA, CAD and PAD, respectively. Experts sug-
gested the following additional complications: access site
pseudoaneurysm, ureteral and bowel lesion for AAA; patch
infection, re-stenosis or occlusion, and contrast
encephalopathy for CAD; decubitus ulcers, loss of sensi-
bility in the leg, re-stenosis or occlusion, and aneurysm
formation for PAD.
Table 2 shows the major and minor complications fol-
lowing intervention in which the surgeons reached con-
sensus per disease. The surgeons reached consensus on 12
major AAA complications, nine CAD complications and
nine PAD complications. They also agreed upon nine, six
and ten minor complications for AAA, CAD and PAD,
respectively. Appendix A provides the complete lists of
complications including severity levels. The experts did not
reach consensus on some complications, including inci-
sional hernia requiring surgical repair (AAA), pulmonary
embolism requiring anticoagulant therapy (CAD), decubi-
tus requiring surgical debridement (PAD).
Discussion
This Delphi study helped vascular surgeons to reach con-
sensus on 9 to 12 major complications following surgery
for AAA, CAD and PAD. Additionally, they reached
consensus on 6 to 10 minor complications. This will give
surgeons the ability to base the complications they discuss
with their patients prior to surgery on these sets of major
complications.
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Fig. 1 Overview of the
modified Delphi method used in
this study
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Understandably, having to discuss up to 12 major
complications may lead to some resistance. This continues
to make the discussion about which complications to dis-
cuss with patients difficult but important. Surgeons want
their patients to feel fully informed about their treatment
options; however, they do not want to overburden or scare
patients by listing all complications, particularly rare but
severe complications. Thus, surgeons may not always
discuss the risk of paraplegia after aortic repair. Never-
theless, it should be noted that most patients want more
information than they currently receive [19]. This was also
evident in two previous Delphi studies, which compared
the patients’ and physicians’ viewpoints regarding infor-
mation that should be discussed prior to treatment [7, 8].
Close examination of legislation and guidelines on the
informed consent procedure shows that differences exist
between countries. Legislation in the UK requires physi-
cians to discuss those risks that a reasonable person in the
patient’s position would deem of significance, or that their
specific patient would deem significant [4]. The Royal
Dutch Medical Association states that physicians must
discuss complications occurring in more than 1% of
patients as well as less frequently occurring major com-
plications [3]. Unfortunately, neither country provides
specific information about the severity and number of
major complications surgeons should discuss with patients.
In general, major complications may require additional
surgery or endovascular treatment, ICU monitoring, or
cause permanent changes. This is why, our participants
rated myocardial infarction, stroke, renal failure and
Fig. 2 Example of feedback presented in Delphi rounds
Fig. 3 International distribution
of participants
Table 1 Characteristics of the participating vascular surgeons
Characteristics Participants*
(N = 46)
Experience in years (mean, SD) 29.31 (8.98)
Interventions performed annually (median, IQR) 58 (30–100)
Male vascular surgeons (%) 90.7
Affiliation with a University Hospital (%) 83.7
N number, SD standard deviation, IQR interquartile range
*Some vascular surgeons participated in surveys for more than one
vascular disease
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Table 2 Major and minor complications following treatment on which the vascular surgeons reached consensus per vascular disease
AAA
Major
Endovascular 1 Allergic reaction (due to contrast allergy) requiring to abort treatment and ventilator support
2 Aneurysm rupture requiring endovascular surgical re-intervention or open surgical repair
3 Vascular graft technical deployment problem requiring conversion to open surgery or development of a permanent
disability and inability to live independently
Open 4 Bowel lesion requiring primary closure or anastomosis or a colostomy
Both 5 Acute myocardial infarction requiring percutaneous coronary intervention or resuscitation
6 Stroke with permanent deficit but the ability to walk without support or with permanent severe impairment and
inability to live independently
7 Renal failure requiring temporary dialysis with permanently reduced renal function requiring surveillance by a
nephrologist or permanent dialysis
8 Thrombo-embolic event requiring minor toe or foot amputation, lytic therapy or fem-fem crossover surgery
9 Vascular graft infection controlled with antibiotics or requiring graft removal with in situ repair
10 Congestive heart failure requiring permanent medication or resuscitation
11 Pulmonary embolism requiring anticoagulant therapy or surgical therapy due to hemodynamic instability
12 Spinal cord ischemia regaining the ability to walk without support within 1 month or permanent paraplegia
AAA
Minor
Endovascular 1 Endoleak type 2 with no evidence of aneurysm expansion requiring additional follow-up imaging or is resolved
after 6 months
2 Vascular graft technical deployment problem without conversion
3 Arterial access site pseudoaneurysm requiring no additional intervention
4 Vascular graft migration requiring no additional intervention
Open 5 Urinary retention requiring one-time catheterization
Both 6 Superficial wound infection requiring opening of the wound at bedside or oral antibiotics
7 Bowel ischemia requiring no additional support
8 Hemorrhage requiring 1 blood transfusion
9 Wound hematoma with spontaneous resolution
CAD
Major
Endovascular 1 Allergic reaction requiring to abort treatment and ventilator support
2 Renal failure requiring temporary dialysis with permanently reduced renal function requiring surveillance by a
nephrologist or permanent dialysis
3 Retroperitoneal hemorrhage requiring both blood transfusion and limited surgical or endovascular intervention for
control or massive transfusion and major open surgical intervention
Open 4 Respiratory distress due to neck hematoma requiring surgical evacuation or nerve compression or cervical blow-out
requiring arterial repair
Both 5 Acute myocardial infarction requiring percutaneous coronary intervention or resuscitation
6 Ipsilateral non-disabling stroke causing prolonged hospital stay, with permanent deficit with mild impairment or
with permanent severe impairment and inability to live independently
7 Carotid artery re-stenosis or occlusion with TIA/minor stroke requiring endovascular or open re-intervention or
with major stroke
8 Embolic or hemodynamic stroke resulting in mild or temporary cognitive function impairment
9 Hyperperfusion syndrome requiring intensive monitor surveillance on brain care unit
CAD
Minor
Endovascular 1 Arterial access site pseudoaneurysm requiring thrombin injection or no additional treatment
Both 2 Bradycardia requiring short-term medicinal support or is resolved within 24 hours
3 Wound hematoma requiring prolonged compression
4 Hypertension requiring medicinal support or is resolved within 24 hours
5 Pulmonary infection requiring IV antibiotics or oral antibiotics
6 Cardiac arrhythmias with spontaneous resolution
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allergic reactions as major complications for all three dis-
eases. However, when observing the other major compli-
cations, it becomes evident that defining a complication as
major depends on the specific disease and treatment.
Moreover, it depends on the outcome of weighing the
benefits of treating the disease against the severity of a
complication, for example, aneurysm rupture following
endovascular aortic repair and stroke after CAD and deep
wound infection for PAD. Evaluation of these diseases and
the complications from Delphi studies on varicose veins,
colorectal and skin cancer shows that every disease
requires its own list of complications [6–8]. Therefore, the
authors recommend that all specialties develop sets of
major complications for each disease they treat to discuss
with their patients.
It is also important to realize that the sets of major
complications obtained in this study are by no means final.
The patients’ viewpoint is currently lacking. Another study
to investigate whether the major complications from this
study match those that patients consider to be major is
ongoing. Adding this knowledge may close the surgeon–
patient information gap and empower vascular patients to
engage in shared decision-making (SDM) [20]. Previous
studies have shown that SDM has a beneficial effect on
quality of care and patient satisfaction [21–23].
However, engaging patients in SDM requires more from
surgeons than just discussing major and frequently occur-
ring complications. This first step toward harmonizing the
complications under discussion is to ensure that all patients
are informed equally about potential complications, which
reduces unwarranted variation. Next, surgeons should help
patients understand the risks involved and explicitly ask
them about their concerns regarding these complications.
Decision support tools for SDM are available to help
patients grasp relevant information concerning the occur-
rence and timing of potential complications, while also
encouraging patients to contemplate their concerns and
preferences [22]. Surgeons must then help patients weigh
the benefits and harms of their own situation. This allows
surgeons to advise their patients about the treatment option
that best fits the patient’s considered opinion and
preferences.
The strengths of this study are first that study partici-
pation was made as easy as possible by using an electronic
questionnaire participants could fill out at any time. In




Endovascular 1 Renal failure requiring temporary dialysis with permanently reduced renal function requiring surveillance by a
nephrologist or permanent dialysis
2 Allergic reaction (due to contrast allergy) requiring to abort treatment and ventilator support
Both 3 Acute limb ischemia due to distal embolization requiring lytic therapy, below-knee amputation or above-knee
amputation
4 Acute myocardial infarction requiring percutaneous coronary intervention or resuscitation or coronary artery
bypass graft surgery
5 Stroke with permanent deficit but the ability to walk without support or with permanent severe impairment inability
to live independently
6 Worsened peripheral artery disease requiring above-knee amputation
7 Pulmonary embolism requiring anticoagulant therapy or surgical therapy due to hemodynamic instability
8 Vascular graft infection controlled with antibiotics or requiring vascular reconstruction
9 Deep wound infection requiring surgical debridement
PAD
Minor
Endovascular 1 Arteriovenous fistula at puncture site requiring no additional intervention
2 Dissection requiring no additional intervention
3 Femoral pseudo-aneurysm at puncture site requiring no additional intervention
Open 4 Transient loss of sensibility on medial side or lower leg
5 Lymphocele or lymphorrhea resolution without aspiration
Both 6 Superficial wound infection requiring opening of the wound at bedside or oral antibiotics
7 Elevated troponin levels requiring surveillance by a cardiologist
8 Pulmonary infection requiring IV antibiotics or oral antibiotics
9 Cardiac arrhythmias with spontaneous resolution
10 Wound hematoma with spontaneous resolution
AAA abdominal aortic aneurysm, CAD carotid artery disease, PAD peripheral artery disease
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complications per round and frequent reminders about
completing the questionnaire. To promote adherence, par-
ticipants received the summary of the previous round and
the next questionnaire within two days following each
round. Second, all participants were experienced vascular
surgeons who reflected the opinions of a number of
countries in Europe and North America. This suggests that
the consensus reached in this study is valid for a wide range
of Western countries. Third, our first Delphi round had
high internal consistency. This implies that the items used
belonged to a single construct, which is likely because all
items were known potential complications following vas-
cular surgical intervention. Fourth, the sets of complica-
tions used were comprehensive, as the experts suggested
only few additional complications.
Limitations of the study are first the relatively small
number of experts per disease who participated fully.
Evidence suggests that the more participants, the lower the
possibility of reaching consensus. Panel sizes of 5–30
participants are recommended, while 5–10 participants per
category are necessary and 15–30 participants in all [24].
Hence, our panel size was considered satisfactory
throughout the study. Second, most participating surgeons
were affiliated to a university hospital. The frequency and
severity with which complications occur may differ
between university medical centers and other medical
centers, due to a different case mix. Thus, all participants
were asked to rate these complications as if they occurred
in a ‘regular’ patient. Third, as the researchers decided to
start the survey with the moderate level of severity of each
complication, where participants did not reach consensus
on the moderate level they did not obtain information on
the severe level. Therefore, consensus on some major
complications may not have been reached. This, however,
holds for a minority of complications.
In conclusion, by means of this Delphi study, an inter-
national panel of vascular surgeons reached consensus on
major complications following treatment for AAA, CAD
and PAD. Vascular surgeons should base the complications
they discuss with their patients prior to surgery on these
sets of major complications. As complications of individual
diseases differ substantially, all specialties should have sets
of complications available for the diseases they treat to
discuss with their patients. The next step is to finalize these
lists by including the patients’ viewpoint and for surgeons
to help patients weigh the benefits against possible com-
plications of each treatment option.
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